Public trading strategy
AstraZeneca's heart drug flops in trials — short the failed-drug fallout
Thesis
When a major drug trial fails, it often triggers a panic sell-off as investors rush to the exits. This selling pressure can cause the stock to fall sharply in a short period as the market re-evaluates the company's future earnings potential without that drug. Since big institutions often dump shares on bad news to manage risk, the downward pressure can linger for several days as the dust settles.
Strategy approach
Build a mean-reversion strategy for AZN on the D1 timeframe. Enter short when the stock drops more than 8% in a single session from the previous close, with a target of a 5% additional downside and a strict 4% upside stop loss. Hold for a maximum of 5 days.
Markets and timeframes
AZND1